Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Use of enamel matrix derivative with immediate implants in the lower back teeth

Official title: Evaluation of Enamel Matrix Derivative in Management of Jumping Gaps Around Immediate Dental Implants in Mandibular Molar Region. A Randomized Clinical Trial

Run by Mansoura University · NCT07727655 · Data updated 2026-11-12

This trial tests whether applying enamel matrix derivative at the time of immediate mandibular molar implants helps osseointegration and healing.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment24 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedSeptember 11, 2026
Main results expectedMarch 2027
Study endsMarch 2027
Registry record updatedSeptember 16, 2026
Trial IDNCT07727655 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–45 needing extraction of a single non-restorable mandibular molar with an immediate implant planned and meeting good oral hygiene and other criteria.

Probably not a fit

Individuals with smoking, pregnancy, bruxism/clenching, active periodontal disease at the site, or other contraindications may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares immediate dental implants placed after extracting a non-restorable mandibular molar, with or without enamel matrix derivative (Emdogain). Outcomes include implant stability and peri-implant bone changes measured over six months using resonance frequency analysis and CBCT imaging. The study is conducted at Mansoura University’s Oral and Maxillofacial Surgery Department and involves 24 patients divided equally between the two groups. The goal is to determine if enamel matrix derivative improves healing and bone preservation around immediate implants in the mandibular molar region.

Why it matters

Potential benefit: If successful, the approach could improve implant stability and bone healing, potentially leading to higher success rates for immediate mandibular molar implants.

How similar studies have gone: Previous research suggests enamel matrix derivatives can aid bone and periodontal healing, but evidence around immediate mandibular implants is still developing and this study adds targeted data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with non-restorable mandibular molar requiring dental extraction.
2. Patient medically free from systemic diseases that absolutely contraindicate implant surgery.
3. Age range: from (18 to 45) years.
4. Adequate inter-arch relation and inter-occlusal space to accommodate the prosthetic restoration (8-12mm).
5. Extraction sockets with intact bony walls and interradicular bone.
6. Jumping gap more than 2mm.
7. Patients with good oral hygiene.
8. Patients willing to participate in the study's follow-up intervals.

Exclusion Criteria:

1. Patients with any pathological lesion or aggressive periodontal disease at the planned surgical site impaired the immediate implant placement.
2. smoker patients.
3. Pregnant patients.
4. Patients with para-functional habits (bruxism and clenching)

Where it's running

  • Faculty of Dentistry, Mansoura University - Oral and Maxillofacial Surgery Department
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.